1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.

Slides:



Advertisements
Similar presentations
CAN I LIE TO YOU? FALSE STATEMENTS, FAILURES TO DISCLOSE AND OTHER SINS IN COMMUNICATING WITH TRIBUNALS By: Bruce A. Campbell Campbell & LeBoeuf P.C.
Advertisements

Technology Center 1600 Training on Writing Rejections Under 35 U.S.C. § 103.
35 U.S.C. § 112, First Paragraph By: Sheetal S. Patel.
Proteomics Examination Yvonne (Bonnie) Eyler Technology Center 1600 Art Unit 1646 (703)
A Practitioners View of Ethical Considerations Before the Board in Interferences Washington, D.C. 10 September 2002 Appellate/Interference Practice in.
Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting October 8, 2002 William F. Smith Administrative Patent Judge Board of Patent Appeals.
UNITED STATES PATENT AND TRADEMARK OFFICE A full transcript of this presentation can be found under the “Notes” Tab. Claim Interpretation: Broadest Reasonable.
DUE PROCESS DEVELOPMENTS IN TERMINATION AND GRIEVANCES.
Patent, Trademark, Copyright, and Enforcement - Law and Policy November 5-8, 2007 United States Patent and Trademark Office Global Intellectual Property.
1 35 USC 112, 1 st paragraph enablement Enablement Practice in TC 1600 Deborah Reynolds, SPE
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
35 U.S.C. 112, Sixth Paragraph MPEP 2181 – 2186 Jean Witz Quality Assurance Specialist Technology Center 1600.
Appeal Practice Before Board of Patent Appeals and Interferences
Maine Board of Tax Appeals 1. What we are: An independent Board of three individuals appointed by the Governor to resolve controversies between Taxpayers.
Invention Spotting – Identifying Patentable Inventions Martin Vinsome June 2012.
Scott F. Johnson Maureen MacFarlane.  Attorneys have a myriad of ethical obligations  This presentation covers some of those obligations and considers.
“REACH-THROUGH CLAIMS”
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
Alaska Mock Trial Glossary of Terms. Laws Rules created by society to govern the behavior of people in society. Among other things, the laws are one formal.
Determining Obviousness under 35 USC 103 in view of KSR International Co. v. Teleflex TC3600 Business Methods January 2008.
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
© 2003 Rule 1.9. Duties to Former Clients (a) A lawyer who has formerly represented a client in a matter shall not thereafter represent another person.
By Paul J. Lee. Disclaimer The opinions and views expressed in these materials are not necessarily those of DexCom and reflect only the personal views.
Secondary Use Patents: An international and Canadian perspective E. Richard Gold James McGill Professor, McGill Faculty of Law Secondary Use Pharmaceutical.
BRIEFING YOUR APPEAL OF AN EXAMINER’S DECISION IN AN INTER PARTES REEXAMINATION Romulo H. Delmendo Administrative Patent Judge Board of Patent Appeals.
Motion for Summary Judgment The Keys to Success. How does this work?  Summary judgments are governed by Rule 166(a) of the Texas Rules of Civil Procedure.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
1 ANTICIPATION BY INHERENCY IN PRIOR ART James O. Wilson Supervisory Patent Examiner Technology Center 1600 USPTO (571)
Broadening the Scope of the Claims in Gene Therapy Applications Deborah Reynolds Detailee, TCPS
Patent Lawyer's Club of Washington October 24, Michael R. Fleming Chief Administrative Patent Judge Changes.
Patent Prosecution Luncheon March White House Patent Reform: Executive Actions Draft rule to ensure patent owners accurately record and regularly.
Professor Peng  Patent Act (2008) ◦ Promulgated in 1984 ◦ Amended in 1992, 2000, and 2008.
California :: Delaware :: Florida :: New Jersey :: New York :: Pennsylvania :: Virginia :: Washington, DC :: Advice for Drafting.
Routine Optimization Jean Witz, tQAS, TC
Model Rules of Professional Conduct Rule 3.3 Candor Toward The Tribunal (a) A lawyer shall not knowingly: (1) make a false statement of fact or law to.
1 LAW DIVISION PATENT DIVISION TRADEMARK & DESIGN DIVISION ACCOUNTING & AUDITING DIVISION YUASA AND HARA LAW, PATENT, TRADEMARK & DESIGN and ACCOUNTING.
Overcoming Prior Art References Non-Enabling Prior Art References Gary Kunz SPE Art Unit 1616.
Christopher J. Fildes Fildes & Outland, P.C. Derivation Proceedings and Prior User Rights.
19/19/07132 Declarations 37 CFR § Practice GENERAL INTRODUCTION.
Post-Grant & Inter Partes Review Procedures Presented to AIPPI, Italy February 10, 2012 By Joerg-Uwe Szipl Griffin & Szipl, P.C.
Unit 3 Seminar! K. Austin Zimmer Any question from Unit 2! Please make sure you have completed your Unit 1 & 2 Papers!
1 Written Description Analysis and Capon v. Eshhar Jeffrey Siew Supervisory Patent Examiner AU 1645 USPTO (571)
Hamre, Schumann, Mueller & Larson, P.C U.S. Patent Claims By James A. Larson.
Mon. Nov. 26. Work Product “Privilege” A witness, X, who is friendly to the D was interviewed by P’s attorney and a statement was drawn up Is there any.
New Sections 102 & 103 (b) Conditions for Patentability- (1) IN GENERAL- Section 102 of title 35, United States Code, is amended to read as follows: -`Sec.
Overview Validity of patent hinges on novelty, utility, and non-obviousness Utility generally not an issue Pre-suit investigation focuses on infringement,
© 2011 Knobbe Martens Olson & Bear LLP © 2011 Kilpatrick Townsend & Stockton, LLP 1 Enhancing Compact Prosecution RCEs and BPAI Appeals The Frequency and.
Examining Claims for Compliance with 35 U.S.C. 112(a): Part II – Enablement Focus on Electrical/Mechanical and Computer/Software-related Claims August.
UNITED STATES PATENT AND TRADEMARK OFFICE
Claims, Anticipation, and Obviousness Kathleen Kahler Fonda Legal Advisor, Office of Patent Legal Administration July 30, 2010.
How to Claim your Biotech- Based Invention Deborah Reynolds Detailee, TCPS
1 Patent Claim Interpretation under Art. 69 EPC – Should prosecution history be used to interpret the patent? presented at Fordham 19th Annual Conference.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
USPTO Guidelines for Determining Obviousness in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc. TC 1600 Biotech/Chem/Pharma.
Double Patenting Deborah Reynolds SPE Art Unit 1632 Detailee, TC1600 Practice Specialist
Prosecution Group Luncheon May, Obviousness—In re Kao (FC 2011) BPAI affirms obviousness rejection: using reference formula, POSA can replace reference’s.
USPTO Guidelines for Determining Obviousness in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc. Kathleen Kahler Fonda Legal.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
© 2011 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is the property of Barnes & Thornburg LLP which may not be reproduced,
BOARD OF PATENT APPEALS AND INTERFERENCES
Processes Which Employ Non-Obvious Products
Ram R. Shukla, Ph.D. SPE AU 1632 & 1634 Technology Center
Law 677 | Patent Law | Spring 2003
Quality Assurance Specialist
Wisdom of the Board Ex parte PTAB Decisions Show Effective Arguments to Overcome an Obviousness Rejection Trent Ostler The content is exclusively the.
Using Image Recognition Software for Searching Designs
The Other 66 Percent: Appeals Before the PTAB
Presentation transcript:

1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences

2 Starting Point You are faced with a prima facie case of obviousness Prima facie case means that viewing only the references and the claimed subject matter, it appears the references may be combined and the conclusion of obviousness is reasonable Also means that the applicant has the burden of presenting evidence demonstrating that the claimed invention has unexpected results You have chosen to take on this burden

3 What are you going to do?

4 Create Evidence for submission to the PTO making comparisons with the prior art

5 “The” most important case Refac International Ltd. v. Lotus Development Corp., 38 USPQ 2d 1665 (Fed. Cir. 1996)

6 “In light of the previous rejection of the [inventor's] affidavit as "self serving," [the inventors] knew that a reasonable Examiner reviewing the Affidavits would conclude that the affiants were disinterested witnesses with no knowledge of the patent process, particularly where the affiants in great detail presented their education and employment history without mention the affiant's connections to the patent applicants or familiarity with the patent invention. Conversely [the inventors] also knew that the PTO Examiner would, when evaluating the Affidavits, consider it important to know whether the disinterested affiants had prior exposure to the patent process or its commercial Program.”

7 “We agree with the following statement made by the Patent Office Committee on Enrollment and Disbarment that considered this case: ‘By reason of the nature of an application for patent, the relationship of attorneys to the Patent Office requires the highest degree of candor and good faith. In its relation to applicants, the Office... must rely upon their integrity and deal with them in a spirit of trust and confidence....’ It was the Commissioner, not the courts, that Congress made primarily responsible for protecting the public from the evil consequences that might result if practitioners should betray their high trust.” Kingsland v. Dorsey, 338 U.S. 318, (1949)

8 ABA Model Rule 3.3(d) Candor Toward the Tribunal (d) In an ex parte proceeding, a lawyer shall inform the tribunal of all material facts known to the lawyer that will enable the tribunal to make an informed decision, whether or not the facts are adverse.

9 The Duty of Candor and Unexpected Results Declarations The declaration must be what you expressly or implicitly represent it to be You must accurately report test results including any unfavorable results Submit objective evidence from a trusted source

10 Back to creating unexpected results evidence Things to keep in mind

11 Applicant bears the burden of persuasion in responding to a prima facie case

12 Unexpected Results Results which would be viewed as surprisingly better or superior by a person of ordinary skill in the art That which is surprising to one having ordinary skill in the art is not predictable nor obvious Merely superior or better is not enough – must be surprisingly or unexpectedly better Proof of synergy does not necessarily prove unexpected results –Synergy– a property which may be unexpected or not based on the particular facts

13 Unexpected results is a factual inquiry Mere argument or conclusory statements by the attorney or a declarant are insufficient to satisfy the applicant’s burden Unexpected results findings by the board are reviewed on appeal using the substantial evidence standard

14 All timely unexpected results evidence must be considered by the examiner

15 Proving results are unexpected The Applicant’s burden is usually satisfied by tests or other data showing improved results compared with the prior art along with declaration testimony that the results are unexpected An objective showing of improved results coupled with attorney argument that the results are unexpected is not ordinarily sufficient

16 Some guidelines when preparing unexpected results declarations

17 Not applicable to § 102 rejections

18 Results must be factual and not merely based on inferences or speculation from the references

19 Unexpected results do not have to be claimed to be relevant to patentability

20 Unexpected Results must have a foundation in applicant’s specification The specification must establish that the property is relevant to the invention In re Chu, 36 USPQ2d 1089 (Fed. Cir. 1995) –“We have found no cases supporting the position that a patent applicant’s evidence and/or arguments traversing a Section 103 rejection must be contained within the specification. There is no logical support for such a proposition as well, given that obviousness is determined by the totality of the record including, in some instances most significantly, the evidence and arguments proffered during the give and take of ex parte patent prosecution.”

21 Apparently contrary precedent In re Wertheim, 191 USPQ 90 (CCPA 1976) In re Slocombe, 184 USPQ 740 (CCPA 1975) In re Davies, 177 USPQ 381 (CCPA 1973)

22 Rationale supporting the necessity of a foundation for unexpected results Unexpected results are part of the invention as a whole If the result is not disclosed in at least a general way or inherently disclosed in the specification, why should the applicant given the filing date for the invention?

23 Comparisons should be “side-by-side ” I.e., Everything should be identical except for the novel features of the invention Any other differences must be sufficiently explained demonstrating that the other differences are not responsible for the results

24 Unexpected results do not have to be demonstrated for all the invention’s properties or possible uses However, the duty of candor may require that you also disclose any tests or information showing results for some properties are inferior to or only as good as the prior art

25 Declarations Should Present a Comparison With the Closest Prior Art The closest prior art is typically the single reference which shares the most features in common with the invention This may not be the art cited by the examiner You need not provide a comparison of the invention with the “primary reference” as modified by secondary references

26 The unexpected property or result must actually be unexpected Expected results are an indicia of obviousness The examiner may cite additional prior art to show that the results in the declaration are expected Synergism is merely a property like any other property - it may be expected or unexpected depending on the particular facts

27 The scope of the showing must be commensurate with the scope of the claimed subject matter The showing must be representative of the full scope of the claimed subject matter Unexpected results as to a single species or single embodiment within the scope of a broad claim may not be sufficient A showing of unexpected results as to the subject matter of a dependent claim may not be sufficient to overcome a rejection of the independent claim Results should not be based upon limitations not required by the claims